Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Synopsys
SNPS
|
+$37.5M |
| 2 |
SoFi Technologies
SOFI
|
+$28.4M |
| 3 |
Rocket Lab Corp
RKLB
|
+$22.8M |
| 4 |
Affirm
AFRM
|
+$22.2M |
| 5 |
Tapestry
TPR
|
+$21.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$615M |
| 2 |
Apple
AAPL
|
+$547M |
| 3 |
Microsoft
MSFT
|
+$522M |
| 4 |
Amazon
AMZN
|
+$310M |
| 5 |
Meta Platforms (Facebook)
META
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.17% |
| 2 | Consumer Discretionary | 11.83% |
| 3 | Communication Services | 10.74% |
| 4 | Healthcare | 9.6% |
| 5 | Industrials | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Sprout Social
SPT
$579M
| $1.3M | ﹤0.01% |
100,541
+1,400
| +1% | +$22.9K |
|
2052
First Financial Corp
THFF
$970M
| $1.29M | ﹤0.01% |
22,926
+300
| +1% | +$17K |
|
2053
Enliven Therapeutics
ELVN
$4.24B
| $1.29M | ﹤0.01% |
63,173
+1,300
| +2% | +$26.2K |
|
2054
Angi Inc
ANGI
$176M
| $1.29M | ﹤0.01% |
79,120
-1,300
| -2% | -$22.3K |
|
2055
Orrstown Financial Services
ORRF
$850M
| $1.28M | ﹤0.01% |
37,600
| – | – |
|
2056
Castle Biosciences
CSTL
$960M
| $1.28M | ﹤0.01% |
56,000
+1,700
| +3% | +$34.5K |
|
2057
Myriad Genetics
MYGN
$309M
| $1.27M | ﹤0.01% |
176,300
| – | – |
|
2058
United Fire Group
UFCS
$1.37B
| $1.27M | ﹤0.01% |
41,900
+700
| +2% | +$20.6K |
|
2059
Merchants Bancorp
MBIN
$2.52B
| $1.27M | ﹤0.01% |
40,000
+600
| +2% | +$19.7K |
|
2060
Accel Entertainment
ACEL
$1B
| $1.27M | ﹤0.01% |
114,800
+17,500
| +18% | +$205K |
|
2061
Geron
GERN
$1.01B
| $1.27M | ﹤0.01% |
926,100
-47,400
| -5% | -$63.1K |
|
2062
Camden National
CAC
$990M
| $1.26M | ﹤0.01% |
32,761
+500
| +2% | +$20.1K |
|
2063
ImmunityBio
IBRX
$8.2B
| $1.26M | ﹤0.01% |
513,500
+92,000
| +22% | +$237K |
|
2064
Marten Transport
MRTN
$1.22B
| $1.26M | ﹤0.01% |
118,475
+1,800
| +2% | +$21.9K |
|
2065
Genco Shipping & Trading
GNK
$1.1B
| $1.26M | ﹤0.01% |
70,800
-7,100
| -9% | -$117K |
|
2066
Independent Bank Corp
IBCP
$850M
| $1.25M | ﹤0.01% |
40,500
| – | – |
|
2067
Arbutus Biopharma
ABUS
$907M
| $1.25M | ﹤0.01% |
276,300
| – | – |
|
2068
Zymeworks
ZYME
$1.77B
| $1.25M | ﹤0.01% |
73,100
| – | – |
|
2069
Under Armour Class C
UA
$2.2B
| $1.24M | ﹤0.01% |
256,500
| – | – |
|
2070
PACS Group
PACS
$7.2B
| $1.24M | ﹤0.01% |
90,200
| – | – |
|
2071
LSI Industries
LYTS
$890M
| $1.24M | ﹤0.01% |
52,400
+1,000
| +2% | +$20.3K |
|
2072
National Presto Industries
NPK
$998M
| $1.23M | ﹤0.01% |
11,000
| – | – |
|
2073
Nurix Therapeutics
NRIX
$2.76B
| $1.23M | ﹤0.01% |
133,400
+2,400
| +2% | +$24.9K |
|
|
GOOS
2074
Canada Goose Holdings
GOOS
$844M
| $1.23M | ﹤0.01% |
89,300
| – | – |
|
2075
EverQuote
EVER
$867M
| $1.23M | ﹤0.01% |
53,700
+1,100
| +2% | +$26.6K |
|
Similar funds
Swiss National Bank's Q3 2025 Portfolio in Review
As of Q3 2025, Swiss National Bank held 2,371 positions worth $172B, up 3.2% from $167B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Swiss National Bank withdrew a net $7.69B in Q3 2025, closing 56 positions and reducing 729 holdings. Its most notable exit was Hess, an estimated $123M position sold in full.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, Swiss National Bank opened a new position in Paramount Skydance Corp worth $11.7M.
- Swiss National Bank's largest Q3 2025 buy was Paramount Skydance Corp: 619,202 shares worth $11.7M.
- Swiss National Bank added most to Synopsys in Q3 2025, an estimated $37.5M increase.
- Swiss National Bank's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $615M.
- Swiss National Bank fully exited Hess in Q3 2025, selling an estimated $123M.
- Swiss National Bank's ten largest holdings make up 36% of its $172B portfolio in Q3 2025.
- Swiss National Bank opened 39 new positions and closed 56 in Q3 2025.
- Swiss National Bank's portfolio value rose 3.2% quarter-over-quarter to $172B.
Based on Swiss National Bank's 13F filing for Q3 2025, filed 13 Nov 2025.